| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 34.18K | 10.29M | 12.73M | 22.03M | 15.47M |
| Gross Profit | 24.49K | 4.17M | 1.86M | 3.70M | 2.54M |
| EBITDA | -28.54K | 235.51K | -431.75K | 1.30M | 914.37K |
| Net Income | -49.40K | -439.34K | -652.73K | 1.07M | 751.67K |
Balance Sheet | |||||
| Total Assets | 144.57K | 12.69M | 10.63M | 9.08M | 7.58M |
| Cash, Cash Equivalents and Short-Term Investments | 4.97K | 2.00M | 1.11M | 3.69M | 1.78M |
| Total Debt | 26.61K | 2.94M | 3.16M | 3.34M | 4.24M |
| Total Liabilities | 33.96K | 5.67M | 7.14M | 6.34M | 5.86M |
| Stockholders Equity | 110.61K | 7.02M | 3.50M | 2.73M | 1.73M |
Cash Flow | |||||
| Free Cash Flow | -32.56K | -1.64M | -3.90M | 687.54K | -1.85M |
| Operating Cash Flow | -31.41K | -1.64M | -3.88M | 1.17M | 1.22M |
| Investing Cash Flow | -62.02K | -365.43K | 1.83M | 743.73K | -3.21M |
| Financing Cash Flow | 84.20K | 2.88M | -398.39K | 45.74K | 2.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | $19.21M | 2.03 | 20.64% | ― | -0.28% | 363.27% | |
49 Neutral | $19.86M | 15.65 | -11.43% | ― | -12.53% | -3.24% | |
48 Neutral | $16.98M | -0.13 | -58.14% | ― | -23.15% | 62.52% | |
44 Neutral | $23.58M | -0.96 | ― | ― | -10.64% | 37.38% | |
43 Neutral | $18.31M | -190.70 | -37.91% | ― | 0.62% | 33.82% | |
43 Neutral | $42.45M | -24.66 | -88.34% | ― | -36.13% | -556.93% |
On February 18, 2026, Linkage Global Inc. entered into a Securities Purchase Agreement with five non-U.S. investors to sell 4,000,000 Class A ordinary shares at $0.50 per share in a private placement for gross proceeds of $2 million. The transaction, conducted under Regulation S, is expected to close on or before March 17, 2026, with proceeds earmarked for general corporate purposes, including working capital and the expansion of the company’s cross-border sales operations.
Under the agreement, Linkage Global plans to file a registration statement with the U.S. Securities and Exchange Commission within 45 days of the deal date to register the newly issued shares, and aims to have it declared effective within 90 to 120 days of filing, depending on regulatory review. The deal structure, including a lock-up period and subsequent registration, is designed to provide fresh capital while managing market impact and enhancing liquidity for investors once the shares become registered.
The most recent analyst rating on (LGCB) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Linkage Global Inc stock, see the LGCB Stock Forecast page.
On February 10, 2026, the board of Linkage Global Inc approved several changes to its membership, with directors Zhiyong Wu and Ryo Fuyunishiki agreeing to step down from the board effective February 13, 2026, while Fuyunishiki will remain as chief operating officer. The company stated the departures were not due to any disagreement over operations or policies, and simultaneously appointed biotechnology and digital health expert Dr. Xunyong Zhou to the board through the next annual general meeting, signaling a push to strengthen its capabilities in health innovation and AI-enhanced solutions.
Dr. Zhou, a 50-year-old entrepreneur, holds more than 20 patents and has led multiple biotechnology and health technology ventures, including roles at Huakang Biomedical Holdings and Nanjing Hezhen Holding Group. His background in enzyme-based product development, cell therapy, and AI-driven health management is expected to bring specialized expertise and broader industry connections to Linkage Global’s governance as it refines its strategic direction.
The most recent analyst rating on (LGCB) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Linkage Global Inc stock, see the LGCB Stock Forecast page.
Linkage Global Inc has called an extraordinary general meeting of shareholders for March 6, 2026, in Fuzhou, China, with February 6, 2026 set as the record date for holders of its Class A and Class B ordinary shares to vote. The meeting notice and proxy materials were filed with the U.S. Securities and Exchange Commission on February 13, 2026, and outline several capital-structure proposals.
Shareholders will be asked to approve an increase in authorized Class B ordinary shares from 2 million to 12 million and corresponding amendments to the company’s memorandum of association to reflect the larger capital base. The agenda also includes a board-discretionary share consolidation of up to 100 existing shares into one new share within two years, with no fractional shares to be issued and any resulting fractions rounded up, along with authority to adjourn the meeting if additional time is needed to secure sufficient votes.
The most recent analyst rating on (LGCB) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Linkage Global Inc stock, see the LGCB Stock Forecast page.
Linkage Global Inc., a cross-border e-commerce services provider headquartered in Tokyo and listed on Nasdaq as LGCB, develops and monetizes consumer electronics-related intellectual property through partnerships and licensing. Its business model combines cross-border product sales with integrated e-commerce solutions, positioning the company to capitalize on global demand for smart devices and branded collaborations.
On February 10, 2026, Linkage Global reported that a successful showcase at CES 2026 and its IP partnership with premium brand ClickClack drove February sales of 72,000 units of licensed products, yielding $720,000 in patent licensing fees. The ClickClack S7 All-Scenario Headphones, built on Linkage Global’s acoustic algorithms and smart wearable technology, were highlighted as CES standouts, and management indicated that if current sales trends hold, the company expects to reach profitability in the first half of 2026, with March order data due by March 5 to gauge continued traction.
The company emphasized that strong market reception for its smart audio-wearable solutions validates the commercial strength of its IP portfolio. Executives said they are using the CES-driven momentum to expand their licensing model globally, signaling a potential shift toward higher-margin IP monetization within the consumer electronics ecosystem.
The most recent analyst rating on (LGCB) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Linkage Global Inc stock, see the LGCB Stock Forecast page.